Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 1, keine Gesamtzahl für „selumetinib“
Suchtreffer
Begriffe & Kennungen
Koselugo · 4.5 · 28 In vitro, selumetinib is an inhibitor of OAT3. The potential for a clinically relevant effect on the pharma
Eintrag öffnenKoselugo · 4.5 · Active substances that may decrease selumetinib plasma concentrations Co-administration with a strong CYP3A4 i
Eintrag öffnenKoselugo · 4.5 · Active substances that may decrease selumetinib plasma concentrations Co-administration with a strong CYP3A4 i
Eintrag öffnenKoselugo · 4.5 · Active substances that may increase selumetinib plasma concentrations Co-administration with a strong CYP3A4 i
Eintrag öffnenKoselugo · 4.5 · Active substances that may increase selumetinib plasma concentrations Co-administration with a strong CYP3A4 i
Eintrag öffnenKoselugo · 4.5 · Active substances whose plasma concentrations may be altered by selumetinib
Eintrag öffnenKoselugo · 4.5 · Active substances whose plasma concentrations may be altered by selumetinib In vitro, selumetinib is an inhibi
Eintrag öffnenKoselugo · 4.5 · Effect of gastric acid reducing agents on selumetinib Selumetinib capsules do not exhibit pH dependent dissolu
Eintrag öffnenKoselugo · 4.5 · Effect of gastric acid reducing agents on selumetinib Selumetinib granules do not exhibit pH dependent dissolu
Eintrag öffnenKoselugo · 4.5 · The effect of selumetinib on the exposure of oral contraceptives has not been evaluated. Therefore, use of an
Eintrag öffnenKoselugo · 4.5 · The effect of selumetinib on the exposure of oral contraceptives has not been evaluated. Therefore, use of an
Eintrag öffnenKoselugo · 4.8 · 8 The safety of selumetinib monotherapy in adult patients has been evaluated in 137 adult patients with NF1 an
Eintrag öffnenKoselugo · 4.8 · In addition, a single event of RPED was reported in a paediatric patient receiving selumetinib monotherapy (25
Eintrag öffnenKoselugo · 4.8 · In addition, a single event of RPED was reported in a paediatric patient receiving selumetinib monotherapy (25
Eintrag öffnenKoselugo · 4.8 · In addition, the safety of selumetinib for the granule formulation was evaluated in 36 paediatric patients (do
Eintrag öffnenKoselugo · 4.8 · In addition, the safety of selumetinib for the granule formulation was evaluated in 36 paediatric patients (do
Eintrag öffnenKoselugo · 4.8 · In the SPRINKLE study, at the time of first data cut-off (DCO1), the median total duration of selumetinib trea
Eintrag öffnenKoselugo · 4.8 · In the SPRINKLE study, at the time of first data cut-off (DCO1), the median total duration of selumetinib trea
Eintrag öffnenKoselugo · 4.8 · Summary of the safety profile The safety of selumetinib monotherapy has been evaluated in a pooled safety popu
Eintrag öffnenKoselugo · 4.8 · Summary of the safety profile The safety of selumetinib monotherapy has been evaluated in a pooled safety popu
Eintrag öffnen